Literature DB >> 9617898

Tyro 3 receptor tyrosine kinase and its ligand, Gas6, stimulate the function of osteoclasts.

Y S Nakamura1, Y Hakeda, N Takakura, T Kameda, I Hamaguchi, T Miyamoto, S Kakudo, T Nakano, M Kumegawa, T Suda.   

Abstract

Bone is continuously being formed and resorbed. This process is accomplished by the precise coordination of two cell types: osteoblasts and osteoclasts. Osteoclasts are large, multinucleated cells that are derived from the same hematopoietic precursors as macrophages. However, these bone-resorbing cells are difficult to study directly because of their relative inaccessibility. The purification of primary osteoclasts from rabbit bones by their adherent nature provides an opportunity for investigating the molecules in osteoclasts. We have examined the expression of receptor tyrosine kinase by polymerase chain reaction (PCR) and found that Tyro 3 was frequently identified from primary osteoclasts in PCR cloning. Immunohistochemistry revealed that Tyro 3 was expressed on the multinucleated osteoclasts which were positive for tartrate-resistant acid phosphatase (TRAP), but not on mononuclear TRAP-positive cells. The Tyro 3 ligand, Gas6, induced the phosphorylation of Tyro 3 receptors in osteoclasts in two to five min. Gas6 and protein S directly enhanced the bone resorbing activity of mature osteoclasts. This effect of Gas6 was inhibited by the addition of a tyrosine kinase inhibitor, herbimycin A. However, Gas6 did not affect the differentiation of osteoclasts from bone marrow cells. Gas6 and protein S are dependent on vitamin K, a cofactor for the enzyme responsible for carboxylation of glutamic acid residues. The findings in this study are the first to indicate a new biological activity of Gas6 and protein S as a direct regulator of osteoclastic function; they give an insight into the role of these vitamin K-dependent ligands in bone resorption in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9617898     DOI: 10.1002/stem.160229

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  22 in total

Review 1.  Macrophage-tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands.

Authors:  Thomas Schmidt; Isabel Ben-Batalla; Alexander Schultze; Sonja Loges
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

2.  GAS6 is a key homeostatic immunological regulator of host-commensal interactions in the oral mucosa.

Authors:  Maria Nassar; Yaara Tabib; Tal Capucha; Gabriel Mizraji; Tsipora Nir; Meirav Pevsner-Fischer; Gili Zilberman-Schapira; Oded Heyman; Gabriel Nussbaum; Herve Bercovier; Asaf Wilensky; Eran Elinav; Tal Burstyn-Cohen; Avi-Hai Hovav
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-03       Impact factor: 11.205

Review 3.  Immunobiology of the TAM receptors.

Authors:  Greg Lemke; Carla V Rothlin
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

4.  Soluble TAM receptor tyrosine kinases in rheumatoid arthritis: correlation with disease activity and bone destruction.

Authors:  L Xu; F Hu; H Zhu; X Liu; L Shi; Y Li; H Zhong; Y Su
Journal:  Clin Exp Immunol       Date:  2017-12-11       Impact factor: 4.330

Review 5.  Regulation of bone remodeling by vitamin K2.

Authors:  V D Myneni; E Mezey
Journal:  Oral Dis       Date:  2017-04-05       Impact factor: 3.511

6.  Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway.

Authors:  K O'Donnell; I C Harkes; L Dougherty; I P Wicks
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

7.  Two genetic loci regulate T cell-dependent islet inflammation and drive autoimmune diabetes pathogenesis.

Authors:  C J Fox; A D Paterson; S M Mortin-Toth; J S Danska
Journal:  Am J Hum Genet       Date:  2000-06-09       Impact factor: 11.025

8.  Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB.

Authors:  Teresa Morgan; Gerald J Atkins; Melanie K Trivett; Sandra A Johnson; Maya Kansara; Stephen L Schlicht; John L Slavin; Paul Simmons; Ian Dickinson; Gerald Powell; Peter F M Choong; Andrew J Holloway; David M Thomas
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

9.  A genomic screen identifies TYRO3 as a MITF regulator in melanoma.

Authors:  Shoutian Zhu; Heiko Wurdak; Yan Wang; Anna Galkin; Haiyan Tao; Jie Li; Costas A Lyssiotis; Feng Yan; Buu P Tu; Loren Miraglia; John Walker; Fanxiang Sun; Anthony Orth; Peter G Schultz; Xu Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-23       Impact factor: 11.205

10.  Dexamethasone inhibits bone resorption by indirectly inducing apoptosis of the bone-resorbing osteoclasts via the action of osteoblastic cells.

Authors:  S Warabi; Y Tachibana; M Kumegawa; Y Hakeda
Journal:  Cytotechnology       Date:  2001-01       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.